Taxonomy Code 1835X0200X(1835x0200x)
Oncology Pharmacist. Providers: 16
Oncology Pharmacist Providers
| NPI | Name | Type | Address |
|---|---|---|---|
|
DR. PHARMD Stephanie Dixon Sutphin |
Individual |
800 Rose St H110 Lexington, KY |
|
|
PHARMD Allison Butts |
Individual |
800 Rose St Rm H110 Lexington, KY |
|
|
PHARMD Alissa Karr |
Individual |
800 Rose St # Wh330 Lexington, KY |
|
|
PHARMD Emily Eastman |
Individual |
800 Rose St Lexington, KY |
|
|
DR. PHARMD, BCOP Mary Lauren Elizabeth Willis |
Individual |
4251 Mooncoin Way Lexington, KY |
|
|
DR. PHARMD, BCOP Elizabeth Ashley Travers |
Individual |
800 Rose St Lexington, KY |
|
|
DR. PHARMD, BCOP Jessica Cupac |
Individual |
800 Rose Street H110 Lexington, KY |
|
|
Morgan Elizabeth Cantley |
Individual |
800 Rose St Rm H110 Lexington, KY |
|
|
PHARMD, BCOP Lauren Dawn Curry |
Individual |
750 Rose St Lexington, KY |
|
|
PHARMD Bryant Clemons |
Individual |
800 Rose St Lexington, KY |
|
|
PHARMD Danielle Otto |
Individual |
University Of Kentucky 800 Rose St Lexington, KY |
|
|
DR. PHARMD Rachael Marie Morgan |
Individual |
800 Rose St Lexington, KY |
|
|
PHARMD Brent Harris |
Individual |
800 Rose St Lexington, KY |
|
|
PHARMD Abby Pike Williams |
Individual |
800 Rose St Lexington, KY |
|
|
PHARMD Ashley Soule |
Individual |
800 Rose St # H110 Lexington, KY |
|
|
DR. PHARMD Kaitlyn Kowalski Bryson |
Individual |
800 Rose St Lexington, KY |
How to obtain, renew, or terminate an NPI
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
| Taxonomy Code | 1835X0200X |
| Specialization | Oncology |
| Display Name | Oncology Pharmacist |
| Taxonomy Group | Pharmacy Service Providers |
| Taxonomy Classification | Pharmacist |
| Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
| Effective Date | September 30, 2009 |